A Two Year Longitudinal Clinical Study of Neurocognitive and Psychiatric Symptoms in Post COVID-19 Patients
The prospective, longitudinal, open observational study monitors patients with cognitive and neuropsychological symptoms after COVID-19 infection, in a longitudinal manner to see how the disease has affected their physical, psychological and cognitive function, their ability to be active, return to work, their health-related quality of life in correlation with potential diagnostic and prognostic markers.
- EligibilityCriteria: Inclusion Criteria:  neurocognitive symptoms after lab-verified COVID-19 infection  Exclusion Criteria:  severe illness e.g cancer with a short expected survival time ongoing alcohol abuse ongoing drug abuse. - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult - StudyPopulation: The patients:  who have been referred for neurocognitive symptoms after Covid-19 infection to secondary health care at Örebro University Hospital (USÖ) or who themselves sought assessment at USÖ who meet inclusion criteria and do not meet exclusion criteria who agreed to study participation with a written informed consent. - SamplingMethod: Non-Probability Sample